MedPath

常州四药制药有限公司

Ownership
-
Established
1996-03-25
Employees
-
Market Cap
-
Website
www.czsiyao-pharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

156

NMPA:156

Drug Approvals

Phloroglucinol Injection

Product Name
间苯三酚注射液
Approval Number
国药准字H20254148
Approval Date
May 13, 2025
NMPA

Minoxidil Liniment

Product Name
米诺地尔搽剂
Approval Number
国药准字H20253969
Approval Date
Apr 22, 2025
NMPA

Nicorandil for Injection

Product Name
注射用尼可地尔
Approval Number
国药准字H20253403
Approval Date
Feb 20, 2025
NMPA

Nicorandil for Injection

Product Name
注射用尼可地尔
Approval Number
国药准字H20253404
Approval Date
Feb 20, 2025
NMPA

Pregabalin Oral Solution

Product Name
普瑞巴林口服溶液
Approval Number
国药准字H20253070
Approval Date
Jan 8, 2025
NMPA

Fluoxetine Hydrochloride Oral Solution

Product Name
盐酸氟西汀口服溶液
Approval Number
国药准字H20249832
Approval Date
Dec 25, 2024
NMPA

Gadobutrol Injection

Product Name
钆布醇注射液
Approval Number
国药准字H20249663
Approval Date
Dec 1, 2024
NMPA

Lacosamide Injection

Product Name
拉考沙胺注射液
Approval Number
国药准字H20249270
Approval Date
Nov 5, 2024
NMPA

Levocetirizine dihydrochloride Oral Solution

Product Name
盐酸左西替利嗪口服溶液
Approval Number
国药准字H20244915
Approval Date
Sep 19, 2024
NMPA

Rocuronium Bromide Injection

Product Name
罗库溴铵注射液
Approval Number
国药准字H20243805
Approval Date
May 28, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.